The Insurer Earning Less on More: UnitedHealth’s Medical Cost Reckoning
For most of the last decade, UnitedHealth Group looked like a machine that printed money the bigger it got. Revenue...
Moe Alsumidaie, MBA, MSF is the Chief Editor of BullScope. Trained in finance, with a Master of Science in Finance and an MBA, he spent years inside large public healthcare companies including Abbott, Genentech, and Roche, learning how the businesses behind the filings actually run. As a journalist and Chief Editor of The Clinical Trial Vanguard, his reporting has appeared in Applied Clinical Trials, The American Journal of Managed Care, and CNET, and has been cited in U.S. Supreme Court proceedings. At BullScope he brings those disciplines together: every note starts in the SEC filings, runs through published methodology, and shows its work.
For most of the last decade, UnitedHealth Group looked like a machine that printed money the bigger it got. Revenue...
In one breath Disney's net margin has climbed from 2.6% in fiscal 2023 to 13.1% in fiscal 2025, the best...
In one breath McDonald's filed numbers show a business earning roughly 32 cents of profit on every dollar of sales,...
In one breath Inflation printed its sharpest monthly drop in six years in June, and financial coverage called it a...
The filing arrived on July 14, 2026. Buried inside JPMorgan's Q2 2026 earnings release was a sentence that stopped us:...
For most of its history, Home Depot has been a mirror held up to the American housing market. When rates...
In one breath Walmart's filed numbers show net margins climbing steadily, from 1.9% in FY2023 to 3.1% in FY2026, even...
The standing BullScope yardsticks for Coca Cola, computed from official filings and refreshed with each new edition.
The standing BullScope yardsticks for Delta Air Lines, computed from official filings and refreshed with each new edition.
The standing BullScope yardsticks for Costco Wholesale, computed from official filings and refreshed with each new edition.
© 2026 BullScope. Evidence-first investment research. Not investment advice. · Methodology · Privacy Policy · Terms of Use · Disclaimer
© 2026 BullScope. Evidence-first investment research. Not investment advice. · Methodology · Privacy Policy · Terms of Use · Disclaimer